Search Results for: lawsuits

MiMedx (MDXG) placental “stem cell magnet” drugs attract FDA attention and lawsuit

ABC News just reported that the FDA is allgedly “cracking down” on the publicly traded company, MiMedx (MDXG), which sells a placental derivative touted for healing powers. The Wall Street Journal is also following the story. According to ABC News: MiMedx is a publically traded, for-profit company that takes donated human placentas — solicited via a website featuring […]

MiMedx (MDXG) placental “stem cell magnet” drugs attract FDA attention and lawsuit Read More »

Interview with Dr. Steven Victor of IntelliCell Biosciences (SVFC)

Steven-Victor-250x3001

What’s the deal with IntelliCell Biosciences, headed up by Dr. Steven Victor? Sometimes science can move at warp speed and that is even more true of the stem cell field. One stem cell establishment that seems to be in a particularly intense period of activity and that has drawn a great deal of attention lately

Interview with Dr. Steven Victor of IntelliCell Biosciences (SVFC) Read More »

Stem Cell Grapevine on Fire: Big Day & Week Ahead for IntelliCell (SVFC)

In the past week I’ve been getting an unprecedented number of emails, blog comments, and even phone calls about IntelliCell Biosciences of NY (stock symbol SVFC). It’s quite remarkable and I’ve had to moderate many comments related to IntelliCell for content not following this blog’s comment rules. The grapevine is smoking hot on this company. It’s

Stem Cell Grapevine on Fire: Big Day & Week Ahead for IntelliCell (SVFC) Read More »

Jeong Chan Ra Arrest: Can RNL Bio (알앤엘바이오) Survive?

Ra

Over at Health in the Global Village, Leigh Turner yesterday published an excellent piece updating us all on the latest news on Korean stem cell company RNL BIo (알앤엘바이오) and its leader, Dr. Jeong Chan Ra (라정찬 ). Addition: The story was reported in several Korean news outlets including Hani here.  A video here by MBC News of Korea, one

Jeong Chan Ra Arrest: Can RNL Bio (알앤엘바이오) Survive? Read More »

Intellicell Inspected By FDA: What Does It Mean?

IntelliCell (SVFC) is a stem cell company that does cosmetic stem cell procedures. They’ve had a number of challenges of late including an FDA warning letter about a year ago and apparent financial issues manifesting in lawsuits. Now the company itself, perhaps trying to get ahead of the news, issued a press release (PR) saying they

Intellicell Inspected By FDA: What Does It Mean? Read More »

Stem cell company Intellicell facing new financial wrinkles

Intellicell

It’s difficult to make it as a biotech company, I would say stem cell biotechs in general may have an even rougher time, and one such company,  Intellicell (Intellicell Biosciences, Inc), is showing a number of signs of distress in my opinion. An online financial tool predicts the probability of companies going bankrupt within the next

Stem cell company Intellicell facing new financial wrinkles Read More »

Texas Judge Issues Complicated Restraining Order in Celltex v. RNL Bio/Human Biostar tussle

Today, a judge issued a complex, temporary restraining order (PDF here, provided by Celltex) regarding Texas stem cell company Celltex and Human Biostar Inc (HBI)/Biostar, former partners who are now in conflict and have sued each other. For more background see here, here, and here. Note that while both parties have sued each other, the judge’s ruling

Texas Judge Issues Complicated Restraining Order in Celltex v. RNL Bio/Human Biostar tussle Read More »

Celltex and former partner RNL Bio/Biostar sue each other: what’s going on?

Celltex is a stem cell company in Texas most well known for Guv Rick Perry’s stem cell transplant. The Celltex business model is to isolate, amplify, and bank patients’ stem cells for subsequent treatment by physicians (for more background including on the FDA role see here and here). Until the last few weeks, an important element

Celltex and former partner RNL Bio/Biostar sue each other: what’s going on? Read More »

Surprising main obstacle to point-of-care stem cell commercialization by small clinics

There is enormous interest in point-of-care for-profit stem cell commercialization by relatively small clinics hoping to hit it big here in the U.S. Some big investors have poured millions into these clinics that are treating patients with adult stem cell therapies. As I’ve talked with some of these folks they expect this market to grow dramatically

Surprising main obstacle to point-of-care stem cell commercialization by small clinics Read More »